Cargando…
GPAHex-A synthetic biology platform for Type IV–V glycopeptide antibiotic production and discovery
Glycopeptide antibiotics (GPAs) are essential for the treatment of severe infectious diseases caused by Gram-positive bacteria. The emergence and spread of GPA resistance have propelled the search for more effective GPAs. Given their structural complexity, genetic intractability, and low titer, expa...
Autores principales: | Xu, Min, Wang, Wenliang, Waglechner, Nicholas, Culp, Elizabeth J., Guitor, Allison K., Wright, Gerard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567792/ https://www.ncbi.nlm.nih.gov/pubmed/33067466 http://dx.doi.org/10.1038/s41467-020-19138-5 |
Ejemplares similares
-
Phylogeny-Informed Synthetic Biology Reveals Unprecedented
Structural Novelty in Type V Glycopeptide Antibiotics
por: Xu, Min, et al.
Publicado: (2022) -
Opportunities for Synthetic Biology in Antibiotics:
Expanding Glycopeptide Chemical Diversity
por: Thaker, Maulik N., et al.
Publicado: (2012) -
Synthetic Biology
Facilitates Semisynthetic Development
of Type V Glycopeptide Antibiotics Targeting Vancomycin-Resistant Enterococcus
por: Koteva, Kalinka, et al.
Publicado: (2023) -
Antibiotic resistance: it’s bad, but why isn’t it worse?
por: Waglechner, Nicholas, et al.
Publicado: (2017) -
Synthetic glycopeptides and glycoproteins with applications in biological research
por: Westerlind, Ulrika
Publicado: (2012)